For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis
ConclusionsMetformin using was associated with an increased OS rate and CS rate of colorectal cancer.
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Databases & Libraries | Diabetes | Endocrinology | Fortamet | Gastroenterology | Metformin | Study